02097nas a2200217 4500000000100000008004100001100001500042700001400057700001400071700001800085700001300103700001900116700001300135700001800148245009900166250001500265300001100280490000700291520153500298020004601833 2012 d1 aScialla J.1 aBeddhu S.1 aParekh R.1 aWoodward Mark1 aAstor B.1 aAnderson Craig1 aAppel L.1 aMiller E. III00aNet endogenous acid production is associated with a faster decline in GFR in African Americans a2012/04/06 a106-120 v823 a
Increased acid excretion may promote renal injury. To evaluate this in African Americans with hypertensive nephrosclerosis, we studied the association between the net endogenous acid production and progression of kidney disease in 632 patients in the AASK trial. Protein and potassium intakes were estimated from 24 h urea nitrogen and potassium excretion, and used to estimate net endogenous acid production, averaged over 2 years, approximating routine intake. The link between net endogenous acid production and the I(125)iothalamate glomerular filtration rate (iGFR) and time to end-stage renal disease or doubling of serum creatinine was analyzed using mixed models and Cox proportional hazards regressions. The trend in higher net endogenous acid production was significantly associated with a faster decline in iGFR over a median of 3.2 years. After adjustment for age, body mass index, baseline iGFR, urine protein-to-creatinine ratio, and randomized treatment group, the trend in higher net endogenous acid production remained significantly associated with a faster decline in iGFR at a rate of 1.01 ml/min per 1.73 m(2) per year faster in the highest compared to the lowest quartile. However, in time-to-event analyses over a median of 7.7 years, the adjusted hazard ratio (1.10) for composite renal events per 25 mEq/day higher net endogenous acid production was not significant. Hence, our findings implicate endogenous acid production as a potential modifiable risk factor for progressive kidney disease.
a1523-1755 (Electronic)0085-2538 (Linking)